Current Status and Clinical Development of Transcatheter Intervention and Surgery for Mitral Regurgitation

  • Osaka Shunji
    Department of Cardiovascular Surgery, Nihon University School of Medicine
  • Tanaka Masashi
    Department of Cardiovascular Surgery, Nihon University School of Medicine

Bibliographic Information

Other Title
  • 僧帽弁閉鎖不全症に対するカテーテル治療と手術治療のそれぞれの特徴と適応について
  • ソウボウベン ヘイサ フゼンショウ ニ タイスル カテーテル チリョウ ト シュジュツ チリョウ ノ ソレゾレ ノ トクチョウ ト テキオウ ニ ツイテ

Search this article

Description

In patients with degenerative mitral regurgitation disease, mitral valve plasty (MVP) is the generally accepted “gold standard” treatment, as it has demonstrated superiority over mitral valve replacement (MVR). However, the role of MVP in the treatment of functional mitral regurgitation remains controversial. Although minimally invasive cardiac surgery (MICS) via right minithoracotomy has attracted attention in Japan in recent years, transcatheter mitral valve intervention has emerged as an effective treatment for mitral regurgitation in patients who are at high risk for surgery. We describe the current status of surgical and transcatheter intervention for mitral regurgitation and our treatment strategy for this disease.

Journal

References(10)*help

See more

Details 詳細情報について

Report a problem

Back to top